SEC Form 4 · accession 0000914190-26-000113
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amy E. Herr
Director
Period of report
Aug 15, 2026
Accepted (ET)
Aug 18, 2026 · 4:12 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2026 | M | 589 | $0.00 | A | 789 | I | By significant other |
| Common Stock | Aug 15, 2026 | F | 213 | $72.40 | D | 576 | I | By significant other |
| Common Stock | holding | — | — | — | 2,680 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF7,F8 | — | Aug 15, 2026 | M | 118 | D | — | — | Common Stock | 118 | 0 | I |
| Restricted Stock UnitsF7,F9 | — | Aug 15, 2026 | M | 160 | D | — | — | Common Stock | 160 | 160 | I |
| Restricted Stock UnitsF7,F11 | — | Aug 15, 2026 | M | 311 | D | — | — | Common Stock | 311 | 621 | I |
| Stock Option (Right to Buy)F1 | $72.05 | holding | — | — | — | — | Feb 3, 2035 | Common Stock | 2,415 | 2,415 | D |
| Stock Option (Right to Buy)F2 | $60.96 | holding | — | — | — | — | Oct 30, 2035 | Common Stock | 3,777 | 3,777 | D |
| Stock Option (Right to Buy)F1 | $66.97 | holding | — | — | — | — | Aug 5, 2027 | Common Stock | 4,472 | 4,472 | I |
| Stock Option (Right to Buy)F1 | $120.46 | holding | — | — | — | — | Aug 6, 2028 | Common Stock | 2,076 | 2,076 | I |
| Stock Option (Right to Buy)F3 | $94.52 | holding | — | — | — | — | Aug 15, 2029 | Common Stock | 2,104 | 2,104 | I |
| Stock Option (Right to Buy)F4 | $84.61 | holding | — | — | — | — | Aug 15, 2030 | Common Stock | 1,084 | 1,084 | I |
| Stock Option (Right to Buy)F5 | $74.91 | holding | — | — | — | — | Aug 15, 2034 | Common Stock | 1,468 | 1,468 | I |
| Stock Option (Right to Buy)F6 | $72.05 | holding | — | — | — | — | Feb 3, 2035 | Common Stock | 344 | 344 | I |
| Restricted Stock UnitsF7,F10 | — | holding | — | — | — | — | — | Common Stock | 77 | 77 | I |
| Stock Option (Right to Buy)F12 | $53.60 | holding | — | — | — | — | Aug 15, 2035 | Common Stock | 2,735 | 2,735 | I |
Explanation of responses
- F1This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
- F1038 restricted stock units vest on 2/3/2027 and 39 restricted stock units vest on 2/3/2028.
- F11311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028.
- F12Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028.
- F2Fully vested.
- F3Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026.
- F4Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
- F5Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
- F6Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
- F7Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F8118 restricted stock units vest on 8/15/2026.
- F9160 restricted stock units vest on each of 8/15/2026 and 8/15/2027.